Advertising Policy
Authorship and Contributorship
Conflicts of Interest
Content Licensing
Data Sharing Policy
Dialogues AI Policy
Direct Marketing
Editorial Governance and Publication Policies
For Authors
For Editors
For Reviewers
Human and Animal Rights
Informed Consent Policy
Manuscript Submission
Open Access Policy
Originality and Plagiarism Screening Policy
Peer Review Policy
Preservation Policy
Quality Control System
Research and Publication Ethics
Dialogues AI Policy

Dialogues in Cardiovascular Medicine (DCM) recognizes the growing use of Generative Artificial Intelligence (AI) tools in scholarly communication. Authors may use AI-assisted tools to improve language, grammar, readability, or formatting of manuscripts; however, authors remain fully responsible for the accuracy, originality, integrity, and content of their work.

 

Generative AI tools must not be listed as authors or co-authors, as they cannot assume responsibility for the submitted work, approve the final manuscript, or fulfill authorship criteria.

 

Authors should disclose the use of Generative AI tools in the preparation of their manuscripts when such use has materially contributed to the writing or development of the content.

 

The journal does not permit the use of AI-generated or manipulated data, images, figures, or research findings that could compromise scientific integrity or mislead readers.

 

This policy is aligned with the principles of the Committee on Publication Ethics (COPE) and internationally recognized scholarly publishing standards.

© Copyright Dialogues in Cardiovascular Medicine